We determined free triiodothyronine (FT3) and free thyroXin (FT4) in serum of patients with various nonthyroidal illnesses (NTI), by both commercial analog-type radioimmunoassays (A) and new equilibrium dialysis procedures (D). The mean FT3 was significantly lower in NTI by both techniques, but the decreases were of different magnitudes. The FT3(D):FT3(A) ratio was 1.96, vs 1.11 for healthy controls. In NTI the mean FT4(D) was somewhat increased, whereas the mean FT4(A) was much lower than normal, the above ratio being 1.70, vs 0.92 for controls. We ascribe these discrepancies, at least in part, to binding of radiolabeled T3-and T4-analog tracers to serum albumin. Our object in the present study was to compare serum FT3 and FT4 concentrations in NTI as determined with our new equilibrium dialysis methods and the recently introduced but already widely used commercial T3-and T4-analog radioimmunoassays (the Amerlex FF3 and FF4 RLA kits). We also investigated the possibility that free thyroid hormone concentrations may be affected differently by different NTIs.
and acute pancreatitis (six cases, ages 33-62 years). The control subjects were 18 women and 22 men, ages 24-85 years. The patients and controls were not known to be taking drugs that interfere pharmacologically or analytically with the assays used in this study. Methods. Our method for determination of serum FF3 involvesuse of a dialysis cellmolded from thermoplastic resin and originally developed for assay of serum Fr4
(details in ref. 6 ). We used a radioimmunoassay technique to determine free hormone fraction in the dialysate. The l'3 antiserum was from Calbiochem-Behring Corp., La Jolla, CA. We prepared 1251-labeled T3 (specific activitity -3000 CiJg) by radioiodination of 3,3'-diiodothyronine (Sigma Chemical Co., St. Louis, MO) with use of Chloramine T. We separated bound and free ligand with dextran-coated charcoal. The average intra-assay coefficient of variation (CV) for Fr3(D) was 5.3%.
The Amerlex FT3 and FT4 RIA kits were purchased from
Amersham
International plc, Amersham, Bucks., U.K. According to the manufacturer, in both kits unspecified analog tracers are used that bind to the same binding sites on antibody as do the natural hormones but have negligible affinity for serum proteins. The intra-assay CV for FT'3(A) was 2.6%, and that for F1'4(A) was 5.2%. We examined the effect of lbumm on F1'3(A) and F1'4(A) by adding incremental amounts of human serum albumin (20-50 gIL), dissolved in 0.15 mmolJL NaCl, to sera from a healthy subject and two NTI patients, one with a low and 
Results
In all the NTI groups we studied, the mean values for serum VF3(D) and FT3(A) were significantly reduced ( significantly greater in NTI patients except for those with heart disease, in whom the increase did not reach statistical significance (Table 1 ). The mean VF4(A) was significantly depressed in all NTI groups. The mean values for thyroxin-binding prealbumin and albumin in serum were strongly depressed in NT! (Table 2 ).
There was a small but significant decrease in mean serum thyroxin-binding globulin. -analog was bound (vs a control value of 76%) and  12% of the T4-analog (vs a control value of 68%) .
Discussion
The validity of the analog assays is based on the assumption that the unidentified radiolabeled analogs bind to antibody but not to serum proteins. However, the observed positive correlation between serum Fr3(A) and albumin in NT! suggests that the low Vl'3(A) concentration is at least partlya result of the decreased serum albumin-an us and others (15, 16) . The mean decrease in FF3(D) was 29%, in F'T3(A)61%, and in FT3I 38%, indicating that FT3I could be a better substitute for VF3(D) in NT! than FI'3(A). Binding of the T4 analog to serum albumin was demonstrated very recently (14, 17, 18) , a finding that we were able to veriQy. The analog assay will therefore underestimate the true serum Fr4 concentration when serum albumin is depressed either due to pregnancy ( 
